

Volume 7, Issue 5 (Suppl)
Epidemiology (Sunnyvale), an open access journal
ISSN: 2161-1165
Epidemiology 2017
October 23-25, 2017
Page 59
conference
series
.com
EPIDEMIOLOGY & PUBLIC HEALTH
October 23-25, 2017 | Paris, France
6
th
International Conference on
Fontaine G H, Epidemiology (Sunnyvale) 2017, 7:5(Suppl)
DOI: 10.4172/2161-1165-C1-016
ATRIAL DYSPLASIAAND THE HIGH FREQUENCY OF ATRIAL FIBRILLATION IN ARVD
PATIENTS
Introduction
: Tonet et al. from Paris were the first to demonstrate a susceptibility of ARVD patients to supraventricular
tachyarrhythmias. This concept was confirmed on larger series of ARVD patients from the USA and Switzerland. It was also
observed by the senior author that atrial fibrillation/tachyarrhythmias (AF/AT) could be the first presentation of the disease.
It was therefore logical to study the atrial pathology of three ARVD patients who died of a non-cardiac cause. This abstract is
the first to present the atrial histology of ARVD patients with comparison to healthy controls considering the typical histologic
changes known in the RV in ARVD.
Methods
: Histology of the right atrium (RA) was available in only 3 cases from a series of 73 ARVD patients, in whom ARVD
was confirmed by pathology. The observed anomalies were adipocytes in two cases, interstitial fibrosis in all, associated with
replacement fibrosis in one case. This prompted us to study the RA structure in four subsequent control patients without
cardiovascular disease. Light microscopic examination with Leica digital image processing was performed. Staining was
performed with HPS in ARVD to improve identification of fibrosis, and HE in the control group.
Results
: The atrial pathology of all of these so-called normal individuals presented anomalies, which can be interpreted as the
background of an atrial arrhythmogenic substrate similar to the recently reported pathology of the RV in ARVD (GF Editorial
AJC 2014). As such, we found adipose tissue, interstitial and replacement fibrosis including one case of lymphocytic infiltration
in the atria of these healthy controls, like histologic changes of the RV observed in ARVD. Furthermore, we identified a
perpendicular orientation of atrial myocardial fibres.
Discussion
:The interface between the two perpendicular layers can be a zone of weakness leading to fat and fibrosis, particularly
if increased loading conditions are present. Desmosomal variants may enhance this remodelling. However, since desmosomal
mutations have not been observed in the normal heart, it is therefore possible to consider other genes or posttranslational
modification to underlay these changes. The unexpected results of this preliminary study need further confirmation. However,
we propose new mechanisms including the role of active as well as healed myocarditis which may precede the development of
AF/AT and explain why these arrhythmias are the most frequent in the human species.
Conclusions
: The same pathological substrate of ventricular myocardium in ARVD is also extending to the atrium explaining
the high frequency of AF in ARVD patients.
Biography
Fontaine G H has made 15 original contributions in the design and the use of the first cardiac pacemakers in the early 60s. He has serendipitously identified ARVD during
antiarrhythmic surgery in the early 70s. He has developed the technique of Fulguration to replace surgery in the early 80s. He has been one of the 216 individuals who
have made a significant contribution to the study of cardiovascular disease since the 14th century and one of the 500 greatest geniuses of the 21st Century (USA Books),
one of the 100 lifetime of achievement (UK Book). He has > 900 publications including 201 book chapters. He is a reviewer of 17 scientific journals both in basic and
clinical science. He has given 11 master lectures of 90 minutes each in inland China in 2014. He is now developing new techniques for brain protection in OHCA, stroke
and spinal cord injury by hypothermia.
guy.fontaine2@numericable.frFontaine G H
Universite Pierre et Marie Curie, France